A DISCRETE EVENT SIMULATION MODEL FOR RENAL CELL CARCINOMA FOR USE IN A COST-EFFECTIVENESS ANALYSIS

被引：0
|
作者：
Dansk, V [1 ]
Treharne, C. [2 ]
Santi, R. [2 ]
Malcolm, B. [3 ]
Johal, S. [2 ]
机构：
[1] PAREXEL, Stockholm, Sweden
[2] Parexel Int, London, England
[3] Bristol Myers Squibb, Uxbridge, Middx, England
来源：
VALUE IN HEALTH | 2017年 / 20卷 / 09期
关键词：
D O I：
10.1016/j.jval.2017.08.2086
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PRM100
引用
收藏
页码：A748 / A748
页数：1
相关论文
共 50 条
  • [41] Cost-effectiveness of omega-3 fatty acid supplements in parenteral nutrition therapy in hospitals: A discrete event simulation model
    Pradelli, Lorenzo
    Eandi, Mario
    Povero, Massimiliano
    Mayer, Konstantin
    Muscaritoli, Maurizio
    Heller, Axel R.
    Fries-Schaffner, Eva
    CLINICAL NUTRITION, 2014, 33 (05) : 785 - 792
  • [42] Cost-effectiveness of diagnostic imaging modalities in symptomatic patients with lower limb peripheral arterial disease: discrete event simulation model
    Kamensky, Vojtech
    Rogalewicz, Vladimir
    Gajdos, Ondrej
    Donin, Gleb
    Maskova, Barbora
    Hola, Martina
    Tichopad, Ales
    FRONTIERS IN PUBLIC HEALTH, 2024, 12
  • [43] USE OF MODEL AVERAGING TECHNIQUES IN COST-EFFECTIVENESS ANALYSIS IN ONCOLOGY
    Le, H. H.
    Ozer-Stillman, I
    VALUE IN HEALTH, 2014, 17 (07) : A556 - A556
  • [44] Lenvatinib plus pembrolizumab for untreated advanced renal cell carcinoma: a systematic review and cost-effectiveness analysis
    Fleeman, Nigel
    Houten, Rachel
    Nevitt, Sarah
    Mahon, James
    Beale, Sophie
    Boland, Angela
    Greenhalgh, Janette
    Edwards, Katherine
    Maden, Michelle
    Bhattacharyya, Devarshi
    Chaplin, Marty
    McEntee, Joanne
    Chow, Shien
    Waddell, Tom
    HEALTH TECHNOLOGY ASSESSMENT, 2024, 28 (49)
  • [45] Cost-effectiveness of routine transoesophageal echocardiography during cardiac surgery: a discrete-event simulation study
    Dieleman, Jan M.
    Myles, Paul S.
    Bulfone, Liliana
    Younie, Sandra
    van Zaane, Bas
    McGiffin, David
    Moodie, Marj
    Gao, Lan
    BRITISH JOURNAL OF ANAESTHESIA, 2020, 124 (02) : 136 - 145
  • [46] Cost-effectiveness of improving patients' adherence to tuberculosis treatment in South Korea using discrete event simulation
    Min, Serim
    Kwon, Sun-Hong
    Lee, Eui-Kyung
    Nam, Jin Hyun
    JOURNAL OF INFECTION AND PUBLIC HEALTH, 2024, 17 (03) : 478 - 485
  • [47] COST-EFFECTIVENESS OF PAZOPANIB AS FIRST LINE TREATMENT FOR METASTATIC RENAL CELL CARCINOMA IN BRAZIL: UPDATED ANALYSIS
    Pepe, C.
    Sedlmayer, C.
    Machado, M.
    VALUE IN HEALTH, 2013, 16 (07) : A685 - A685
  • [48] COST-EFFECTIVENESS ANALYSIS OF CURRENT TREATMENT GUIDELINES FOR WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS IN THE US (a)over-cap(sic)" A DISCRETE-EVENT SIMULATION MODEL
    Le, Q.
    Delevry, D.
    VALUE IN HEALTH, 2019, 22 : S243 - S243
  • [49] THE USE AND MISUSE OF COST-EFFECTIVENESS ANALYSIS
    GASPARI, KC
    SOCIAL SCIENCE & MEDICINE, 1983, 17 (15) : 1043 - 1046
  • [50] COST-EFFECTIVENESS OF BRIVARACETAM VERSUS OTHER ANTIEPILEPTIC DRUGS USED AS ADJUNCTIVE TREATMENT FOR FOCAL SEIZURES IN THE UK: A DISCRETE EVENT SIMULATION MODEL
    Charokopou, M.
    Sander, J.
    Saha, R.
    Beard, S.
    Kidd, R.
    Coward, E.
    Plumb, J.
    VALUE IN HEALTH, 2016, 19 (07) : A365 - A365
12345